Nanobiotix S.A. Research and Development Expense
Nanobiotix S.A. (NNBXF) reported Research and Development Expense of EUR 23.11 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2026-03-31
| Period end | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|
| 2025-12-31 | 23.11M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | 14.53M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | 40.54M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 21.99M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | 38.40M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | 17.80M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | 32.64M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | 16.61M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 30.38M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | 15.51M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | 24.33M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | 13.08M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | 30.41M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | 20.89M EUR 20-F/A · filed 2021-04-08 |